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Discussion
The successful management of an aortoesophageal fistula remains
a challenge.1-4 Moreover, therapeutic procedures are even more
complicated in patients with a right-sided aortic arch. To date, 3
cases of an aortoesophageal fistula have been described in patients
with a right-sided aortic arch, 2 of whom died as the result of a
massive hematemesis.1-3 In addition to open surgery, endovascular
approaches with stent-grafts to treat aortoesophageal fistulas have
been described.4,5 Although the presented cases thus far underwent
open surgery, our patient underwent an endovascular procedure by
introducing a stent-graft in the aortic arch after an unsuccessful
suture. To our knowledge, this is the first successful endovascular
reconstruction of an aortoesophageal fistula in a patient with a
right-sided aortic arch. However, the long-term outcome of endo-
vascular therapy remains to be determined, because a recurrent
aortoesophageal fistula developed in our patient, necessitating
open surgery.
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Four thymus-related syndromes in a case of invasive thymoma
Marco Lucchi, MD,a Andrea Viti, MD,a Roberta Ricciardi, MD,b Luigi Murri, MD,b and Alfredo Mussi, MD,a Pisa, Italy
Thymoma is an epithelial tumor that is frequently asso-ciated with autoimmune phenomena and paraneoplasticsyndromes. The most frequent are neuromuscular1 andhematologic2 disorders; however, neurologic,3 derma-
tologic,4 ophthalmologic, and other disorders are reported.5 The
surgical resection of the tumor and associated adjuvant therapies
often result in an improvement or complete remission of the
symptoms. On the other hand, a thymus-related syndrome some-
times develops months or years after the treatment of the
thymoma.1 Moreover, the recurrence of thymoma may be accom-
panied by recurrence of the originally associated paraneoplastic
syndrome, even after many years.
The association of 2 or more paraneoplastic syndromes is rare
in any case. We report a unique case of invasive thymoma and 4
thymus-related syndromes occurring in the preoperative setting.
Clinical Summary
A 43-year-old man with recurrent fever and limb petechiae was
admitted to the internal medicine division of our hospital. Serum
platelet count was 16  103/L, red cell count was 2.9  106/L,
and hemoglobin concentration was 8.2 g/dL. The diagnosis of pure
red cell aplasia and idiopathic thrombocytopenic purpura was
made.
The marrow biopsy showed 1) a well-represented granuloblas-
tic group with hyperplastic phenomenon, without morphologic
anomalies; 2) a low presentation of red cells with some erythro-
blastic cells, and 3) anomalies in the distribution of lymphoid cells.
The patient also presented with a rheumatologic disease char-
acterized by intense pain localized at the fingers and arms, which
was treated with nonsteroidal anti- inflammatory drugs. The ane-
mia and thrombocytopenia were treated with transfusions.
A standard chest x-ray evidenced the presence of a voluminous
mass of the anterior and superior mediastinum prominent on the
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Figure 2. Angiogram showing the coiling of the left subclavian
artery.
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right side. A chest computed tomographic (CT) scan confirmed the
presence of an irregular mass (57  75  100 mm) in the anterior
mediastinum, compressing the right vascular structures (Figure 1).
The patient was then referred to the division of thoracic surgery
with the clinical diagnosis of mediastinal tumor with red cell
aplasia, thrombocytopenia, and undefined rheumatologic syn-
drome. After the neurologic evaluation, myasthenia gravis was
demonstrated with a high titer of acetylcholine receptor antibody.
During the preoperative period, the patient required transfusion
of 3 units of platelets and 2 units of red cells. The preoperative
blood test results were as follows: platelet count of 35  103/L,
red cell count of 3.39  106/L, mean cell volume of 82.4 fL, and
hemoglobin concentration of 10 g/dL.
The lesion was radically resected through a median longitudi-
nal sternotomy. During the procedure, another unit of platelets was
administered. The postoperative course was uneventful, and the
patient did not require any further transfusion.
The pathologic study described a “Thymoma with rich lymph-
ocritical component, extensively infiltrating the mediastinal fat.
The capsula is infiltrated in many parts.”
A recent pathologic review, according to the new World Health
Organization classification, defined the tumor as “Thymoma B2 in-
filtrating the capsula and the mediastinal fat; Masaoka stage IIB.” At
the discharge 1 week later, the patient showed the following labora-
tory values: red cell count of 3.16  106/L, hemoglobin concentra-
tion of 9.3 g/dL, hematocrit level of 26.9%, and platelet count of 372
 103/L. The patient was referred for mediastinal radiotherapy (50
Gy), but after 2 fractions he refused the treatment.
At the 3-month follow-up, the patient’s hematologic status was
completely recovered. Myasthenia gravis was initially controlled
with anticholinesterase and steroid therapy, and then the patient
had a complete remission without drugs. The rheumatologic symp-
toms were still present, and the patient underwent long-term ther-
apy with disease-modifying antirheumatic drugs.
At the last follow-up, 5 years after the operation, the chest CT
evidenced the presence of a rounded, solid, 3-cm–wide lesion
localized on the right mediastinal pleura (Figure 2).
The mass on the visceral pleura of the superior right lobe
was removed by a posterolateral thoracotomy, and hyperthermic
(42°C) intrapleural chemotherapy with cisplatin and epidoxorubi-
cin was performed.
Discussion
Paraneoplastic syndromes associated with thymomas are often
characterized by an underlying autoimmune mechanism. Thymo-
mas are often associated with defects of T-cell maturation, leading
to tolerance breakage.1
Myasthenia gravis is associated with thymomas in 30% to 45%
of the cases, sometimes as the first symptom. Pure red cell aplasia
is present in 5% to 10% of the cases, and the association between
thymoma and thrombocytopenia has been observed in a few cases.
In our patient, both of these improved in the immediate post-
operative period, emphasizing their strict correlation to the tumor.
Although the tumor appeared invasive at the CT, we judged it
resectable and the patient not eligible for neoadjuvant chemother-
apy because of the hematologic symptom.
Remission of pure red cell aplasia after thymectomy is reported
in 25% to 30% of cases, but usually it requires some adjuvant
therapies such as cyclosporine and antithymocyte globulin.2
The rheumatic symptom slightly decreased on the second post-
operative day, but 1 month from the removal of the pleural
recurrence, the pain was still present and the specific therapy
(steroids and disease-modifying antirheumatic drugs) is ongoing.
Although some thymus-related disorders in patients with thy-
momas are well described in the literature, the presence of 4
syndromes in the same patient is unique and to our knowledge has
never been reported.
Figure 1. Chest CT scan of the mediastinal mass.
Figure 2. Chest CT scan 5 years after
the operation showing the presence of
a right pleural recurrence (white ar-
row). At the time of thoracotomy, the
lesion localized on the visceral pleura
of the upper right lobe.
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It is advisable for physicians to exclude the possibility of a
paraneoplastic thymoma–related syndrome whenever a patient
with a thymoma does not have well-defined complaints.
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